Back to top
more

Cigna Group (CI)

(Delayed Data from NYSE)

$315.22 USD

315.22
2,655,167

-3.17 (-1.00%)

Updated Nov 6, 2024 04:00 PM ET

After-Market: $315.09 -0.13 (-0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 26% (184 out of 251)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Can UnitedHealth's (UNH) UnitedHealthcare Unit Aid Q4 Earnings?

by Zacks Equity Research

UnitedHealth's (UNH) fourth-quarter results are expected to benefit from an increase in UnitedHealthcare's Medicare & Retirement revenues as well as the number of people it served.

Are Medical Stocks Lagging Cigna Group (CI) This Year?

by Zacks Equity Research

Here is how Cigna (CI) and Akoya Biosciences (AKYA) have performed compared to their sector so far this year.

Can UnitedHealth (UNH) Q4 Earnings Navigate Through High Costs?

by Zacks Equity Research

UnitedHealth's (UNH) fourth-quarter results are likely to reflect growth in domestic commercial customers and premium levels.

Cigna (CI) Ascends But Remains Behind Market: Some Facts to Note

by Zacks Equity Research

Cigna (CI) closed the most recent trading day at $313.63, moving +0.01% from the previous trading session.

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

by Zacks Equity Research

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Is Cigna (CI) Nearing a Medicare Advantage Divestment Deal?

by Zacks Equity Research

Cigna's (CI) Medicare Advantage unit's divestment is expected to fetch around $3-$4 billion.

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

by Zacks Equity Research

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Will Cigna (CI) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Here's Why Cigna (CI) is a Strong Value Stock

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Cigna (CI) Ascends While Market Falls: Some Facts to Note

by Zacks Equity Research

Cigna (CI) concluded the recent trading session at $299.45, signifying a +0.02% move from its prior day's close.

Why You Should Retain Cigna (CI) Stock in Your Portfolio

by Zacks Equity Research

Cigna's (CI) strong Evernorth and Cigna Healthcare segments, growing medical membership and a positive 2023 outlook poise it well for growth.

Cigna (CI) Exceeds Market Returns: Some Facts to Consider

by Zacks Equity Research

In the latest trading session, Cigna (CI) closed at $294.32, marking a +0.77% move from the previous day.

Cigna (CI) Laps the Stock Market: Here's Why

by Zacks Equity Research

The latest trading day saw Cigna (CI) settling at $292.07, representing a +0.54% change from its previous close.

Cigna's (CI) Medicare Advantage Unit Draws Acquisition Interest

by Zacks Equity Research

The final bids for Cigna's (CI) Medicare Advantage unit are expected next week.

The Zacks Analyst Blog Highlights The Home Depot, Advanced Micro Devices, Pfizer, The Cigna Group and Live Nation Entertainment

by Zacks Equity Research

The Home Depot, Advanced Micro Devices, Pfizer, The Cigna Group and Live Nation Entertainment are part of the Zacks top Analyst Blog.

Cigna (CI) Stock Falls Amid Market Uptick: What Investors Need to Know

by Zacks Equity Research

Cigna (CI) closed at $296.71 in the latest trading session, marking a -1.74% move from the prior day.

Sheraz Mian headshot

Top Stock Reports for Home Depot, Advanced Micro Devices & Pfizer

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including The Home Depot, Inc. (HD), Advanced Micro Devices, Inc. (AMD) and Pfizer Inc. (PFE).

Strength Seen in Cigna (CI): Can Its 16.7% Jump Turn into More Strength?

by Zacks Equity Research

Cigna (CI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Company News for Dec 12, 2023

by Zacks Equity Research

Companies In The News Are: M, CI, HUM, OXY, HAS.

Cigna (CI) Adds $10B to Buyback Funds, Turns to Bolt-On Buyouts

by Zacks Equity Research

Cigna (CI) expects to maintain average annual adjusted EPS growth within 10-13% in the long term.

Here's Why Cigna (CI) is a Strong Growth Stock

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Kaibalya Pravo Dey headshot

Analyzing Cigna & Humana Merger Talks: Opportunities & Obstacles

by Kaibalya Pravo Dey

The Cigna-Humana merger will provide the combined body with increased negotiation power with healthcare providers, pharmaceutical companies and other stakeholders.

Shaun Pruitt headshot

Time to Buy Cigna (CI) or Humana's (HUM) Stock on News of a Potential Merger?

by Shaun Pruitt

News of a potential mega-merger between Cigna (CI) and Humana (HUM) made headlines in today's trading session and investors may be wondering if now is a good time to buy stock in these health giants.

Sheraz Mian headshot

Top Stock Reports for McDonald's, Amgen & NextEra Energy

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including McDonald's Corporation (MCD), Amgen Inc. (AMGN) and NextEra Energy, Inc. (NEE).

Here's Why Investors Should Hold Cigna (CI) Stock for Now

by Zacks Equity Research

Cigna (CI) expects total medical customer growth to be a minimum of 1.4 million this year.